Stock Events

Stock Events

Larimar Therapeutics (LRMR) Q4 2025 Earnings

5NovConfirmed

Q4 2024

Q2 2025

Q3 2025

Q4 2025

-0.61

-0.49

-0.36

-0.24

Details

Expected EPS

-0.403694

Actual EPS

-0.61

Surprise EPS

-0.21

Surprise Percent

+51.1%

Description

Larimar Therapeutics (LRMR) has reported earnings of -0.61 per share for Q4 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.